Xanthic Biopharma & Green Growth Brands Complete Business Combination


Ryan Allway

November 12th, 2018

News


Xanthic Biopharma Inc. (formerly Aurquest Resources Inc.) (“Xanthic“) (CSE: xTHC) and Green Growth Brands Inc. (“GGB“) are pleased to announce that they have completed the previously announced Business Combination (defined below) between Xanthic and GGB (see The Business Combination below). Following closing, Xanthic will continue under the corporate name “Xanthic Biopharma Inc.” until the first quarter of 2019, following which time it is expected to change its corporate name to “Green Growth Brands Ltd.” (the combined entity, following completion of the Business Combination is referred to as “we“, the “Company” or  the “Resulting Issuer“).  Until such time the Company will operate in Ontario under the business name “Green Growth Brands”.

It is anticipated that the common shares of the Company will resume trading on the facilities of the Canadian Securities Exchange under the ticker symbol “GGB” on November 13, 2018 (see Conditional Listing Approval below).

“The completion of the business combination gives retail and institutional investors a chance to participate in our growth story as we build a premium North American retailer of cannabis, THC and CBD products,” said Peter Horvath, CEO of the Company’s operating entity. “We have built and led industry-leading retail organizations before, and we will do it again by keeping the consumer at the center of everything we do.”

About the Company:

The combined Company is a lifestyle oriented, consumer products company that celebrates health, wellness and happiness.  We are in the business of cultivation, processing and retailing of cannabis, tetrahydrocannabidol (“THC“), cannabidiol (“CBD“) and cannabis-infused consumer products.  Over the next 12 months, the Company intends to expand its retail and wholesale cannabis businesses as well as its CBD consumer products business through a combination of strategic partnerships, merger and acquisition activity, and organic license capture.  The Company’s objectives are to establish retail cannabis locations, or otherwise apply for such licenses, in various states within that timeframe, pursuant to state laws.  Such activity will focus on those certain states where cannabis has been legalized for medical and/or recreational use at the state level.

Conditional Listing Approval

Xanthic received conditional approval of the Business Combination from the Canadian Securities Exchange (the “CSE” or the “Exchange“) on November 7, 2018. The Business Combination remains subject to the final approval of the CSE, which is expected to be received on or about November 9, 2018. It is currently anticipated that trading of the common shares of the Resulting Issuer will commence on the CSE on or about November 13, 2018 under the ticker symbol “GGB”. There is no assurance that the Resulting Issuer will ultimately be able to satisfy the listing requirements of the CSE.

Summary of the Shareholder Meetings:

On October 29, 2018, GGB held a special meeting of shareholders of GGB (the “GGB Shareholders“), where the GGB Shareholders approved, among other things, the Business Combination.

As previously announced, on November 2, 2018, Xanthic held an annual and special meeting of shareholders of Xanthic (the “Xanthic Shareholders“), where Xanthic Shareholders approved, among other things, a name change, the Business Combination, an amendment to Xanthic’s articles of incorporation to create a new class of proportionate voting shares and the consolidation of the common shares of Xanthic immediately following closing of the Business Combination.

Further details on the Business Combination are set out in the management information circular of Xanthic dated October 12, 2018, which is available on SEDAR at www.sedar.com.

The Business Combination

On July 13, 2018, GGB and Xanthic entered into an arm’s length business combination agreement (the “Definitive Agreement“), which was subsequently amended and restated on October 30, 2018. Pursuant to the Definitive Agreement, Xanthic completed the business combination with GGB by way of a three-cornered amalgamation pursuant to which GGB amalgamated with a wholly-owned subsidiary of Xanthic to form one company as a wholly-owned subsidiary of Xanthic (the “Business Combination”).  As previously announced, GGB completed a brokered and non-brokered private placement of 12.00% unsecured convertible debentures of GGB (the “Convertible Debentures“) pursuant to the terms of a debenture indenture dated August 30, 2018among GGB and Capital Transfer Agency ULC (the “Debenture Indenture“). Pursuant to the terms of the Debenture Indenture, the Convertible Debentures automatically converted on the closing date of the Business Combination into that number of common shares of GGB and common share purchase warrant of GGB as results from the application of the conversion formula as provided in the Debenture Indenture. GGB has elected to satisfy all interest that has accrued on the Convertible Debentures in cash as permitted by the terms of the Debenture Indenture.

In addition, GGB issued 12.00% unsecured convertible debentures of GGB (the “PVS Debentures“) in consideration for the purchase for cancellation of certain Convertible Debentures, which pursuant to the terms of the PVS Debentures, converted on the closing date of the Business Combination into that number of proportionate voting shares of GGB and proportionate voting share purchase warrants of GGB as results from the application of the conversion formula as provided in the certificate evidencing the PVS Debentures. GGB has elected to satisfy all interest that has accrued on the PVS Debentures in cash as permitted by the terms of the certificate evidencing the PVS Debentures.

As part of the Business Combination, each of the common shares, proportionate voting shares, common share purchase warrants and proportionate voting share warrants of GGB (collectively, the “GGB Securities“) will be cancelled and former GGB securityholders will receive 3.43522878 common shares, proportionate voting shares, common share purchase warrants, and proportionate voting share warrants of Xanthic, as applicable, for each GGB Security so cancelled (collectively, the “Consideration Securities“). The common shares of Xanthic (including the Consideration Securities) have also been consolidated on the basis of four (4) pre-consolidation shares for one (1) post-consolidation Resulting Issuer common share.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading